Navigation Links
Why Investors Still See Value in Alkermes, AMAG Pharmaceuticals, IDEXX Laboratories and Atossa Genetics?
Date:5/19/2016

NEW YORK, May 19, 2016 /PRNewswire/ --

The equities market is never short of surprises, and one sector that is always abounding of surprises is without doubt the Healthcare space. ActiveWallSt.com has uncovered four stocks in the Healthcare sector ahead of today's trading session: Alkermes PLC (NASDAQ: ALKS), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), IDEXX Laboratories Inc. (NASDAQ: IDXX), and Atossa Genetics Inc. (NASDAQ: ATOS). Sign up for your complimentary alerts at:

http://www.activewallst.com/

On Wednesday, Alkermes PLC's stock climbed 0.63%, to close the day at $40.23 with a total volume of 593,666 shares traded. The Company's shares have advanced 22.47% in the previous three months. The stock is trading 9.78% above its 50-day moving average. Additionally, shares of Alkermes have a Relative Strength Index (RSI) of 57.96. Sign up and activate your free alert on ALKS at:

http://www.activewallst.com/

Shares in AMAG Pharmaceuticals Inc. saw a correction of 1.55%, finishing Wednesday's session at $18.46. The stock recorded a trading volume of 1.08 million shares. The Company's shares are trading below their 50-day moving average by 21.24%. Furthermore, AMAG Pharmaceuticals' stock has an RSI of 30.42. The complimentary trade alert on AMAG can be accessed at:

http://www.activewallst.com/

IDEXX Laboratories Inc.'s stock finished 1.26% higher at $88.33 at yesterday's close. A total volume of 940,462 shares was traded, above their three months average volume of 688,200 shares. The Company's shares have advanced 9.97% in the past month, 25.06% over the previous three months, and 21.13% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 9.39% and 19.04%, respectively. Additionally, shares of IDEXX Laboratories have an RSI of 71.24. Register for free on ActiveWallSt.com and activate the trade alert on IDXX at:

http://www.activewallst.com/

Shares in Atossa Genetics Inc. saw a correction of 6.04%, ending the session at $0.26. The stock recorded a trading volume of 313,863 shares. The Company's shares are trading 16.22% below their 50-day moving. Moreover, Atossa Genetics' stock has an RSI of 42.95. ATOS free trade alert is just a click away at:

http://www.activewallst.com/

Active Wall Street: 

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

AWS has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com

CONTACT:
For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number:  1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


'/>"/>
SOURCE Chelmsford Park SA
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. With Donghai Securities and the German Startups Group, Fiagon AG has added two new investors with a total investment of 7.5 million euros
2. Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against GW Pharmaceuticals PLC (GWPH) and Lead Plaintiff Deadline: March 21, 2016
3. Mylan to Present at the Raymond James 37th Annual Institutional Investors Conference
4. Haemonetics to Present at the Raymond James 37th Annual Institutional Investors Conference
5. HeartWare Presentation At The Raymond James 37th Annual Institutional Investors Conference To Be Webcast
6. Diplomat to Participate in the Raymond James & Associates 37th Annual Institutional Investors Conference
7. RegeneRx Meeting with Institutional Investors and Analysts At BIO CEO Conference
8. BioLife Solutions to Present at 18th Annual BIO CEO & Investors Conference
9. Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against HeartWare International, Inc. and Lead Plaintiff Deadline: March 22, 2016
10. Anpac Bio Receives Series B Funding from Shanghai Zhangjiang Science & Technology Investment Corp & Private Insurance Investors
11. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aoxing Pharmaceutical, Inc. - AXN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):